265 related articles for article (PubMed ID: 28936734)
21. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
22. An exosomal-carried short periostin isoform induces cardiomyocyte proliferation.
Balbi C; Milano G; Fertig TE; Lazzarini E; Bolis S; Taniyama Y; Sanada F; Di Silvestre D; Mauri P; Gherghiceanu M; Lüscher TF; Barile L; Vassalli G
Theranostics; 2021; 11(12):5634-5649. PubMed ID: 33897872
[TBL] [Abstract][Full Text] [Related]
23. Reviewing the role of cardiac exosomes in myocardial repair at a glance.
Koohsarian P; Talebi A; Rahnama MA; Zomorrod MS; Kaviani S; Jalili A
Cell Biol Int; 2021 Jul; 45(7):1352-1363. PubMed ID: 33289229
[TBL] [Abstract][Full Text] [Related]
24. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
25. Cardiac Extracellular Vesicles in Normal and Infarcted Heart.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26742038
[TBL] [Abstract][Full Text] [Related]
26. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system.
Meiners S; Dreger H; Fechner M; Bieler S; Rother W; Günther C; Baumann G; Stangl V; Stangl K
Hypertension; 2008 Feb; 51(2):302-8. PubMed ID: 18086945
[TBL] [Abstract][Full Text] [Related]
27. Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.
Sassi Y; Ahles A; Truong DJ; Baqi Y; Lee SY; Husse B; Hulot JS; Foinquinos A; Thum T; Müller CE; Dendorfer A; Laggerbauer B; Engelhardt S
J Clin Invest; 2014 Dec; 124(12):5385-97. PubMed ID: 25401477
[TBL] [Abstract][Full Text] [Related]
28. Heart Development, Diseases, and Regeneration - New Approaches From Innervation, Fibroblasts, and Reprogramming.
Ieda M
Circ J; 2016 Sep; 80(10):2081-8. PubMed ID: 27599529
[TBL] [Abstract][Full Text] [Related]
29. Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology.
Marini M; Ibba-Manneschi L; Manetti M
Adv Exp Med Biol; 2017; 998():237-254. PubMed ID: 28936744
[TBL] [Abstract][Full Text] [Related]
30. Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease.
Zhang X; Sun S; Ren G; Liu W; Chen H
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003385
[TBL] [Abstract][Full Text] [Related]
31. Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy.
Mao L; Li YD; Chen RL; Li G; Zhou XX; Song F; Wu C; Hu Y; Hong YX; Dang X; Li GR; Wang Y
J Nanobiotechnology; 2022 Oct; 20(1):435. PubMed ID: 36195937
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
[TBL] [Abstract][Full Text] [Related]
33. Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis.
Vanhaverbeke M; Gal D; Holvoet P
Adv Exp Med Biol; 2017; 998():45-58. PubMed ID: 28936731
[TBL] [Abstract][Full Text] [Related]
34. Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart.
Davidson SM; Padró T; Bollini S; Vilahur G; Duncker DJ; Evans PC; Guzik T; Hoefer IE; Waltenberger J; Wojta J; Weber C
Cardiovasc Res; 2021 Aug; 117(10):2161-2174. PubMed ID: 34114614
[TBL] [Abstract][Full Text] [Related]
35. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of the CD151 protects the cardiac function by the crosstalk between the endothelial cells and cardiomyocytes via exosomes.
Jiang L; Liu J; Yang Z; Wang J; Ke W; Zhang K; Zhang C; Zuo H
PLoS One; 2024; 19(2):e0297121. PubMed ID: 38349935
[TBL] [Abstract][Full Text] [Related]
37. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease.
Suzuki E; Fujita D; Takahashi M; Oba S; Nishimatsu H
Adv Exp Med Biol; 2017; 998():179-185. PubMed ID: 28936740
[TBL] [Abstract][Full Text] [Related]
40. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
